Parmax Pharma Limited

Main products: Aripiprazole,Nebivolol Hydrochloride,Voglibos,1,10 – Dichloro Decane,Piracetam I.P.

Current Location: Manufacturer >> Parmax Pharma Limited
COMPONY INTRODUCTION
Enterprise Certification: Learn more about us >
Welcome to Parmax Pharma Ltd.The Company was incorporated on 02.11.1994. The certificate of commencement of business was received by the company on 10.03.1995.The IPO of the company was 30.01.1996 with 5100800 shares of Rs10/-each. The promoters were earlier in manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The company then discontinued its business activities for few years due to various reasons. The company also plans to extend its activity in formulation of Tablets, Capsules, Ointments, & Injectable.Our BusinessThe active pharmaceutical ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax’s pharmaceutical operations. Starting from our journey as a bulk drug manufacturer and speciality chemicals in 1994.We leverage our scientific expertise and strong manufacturing capabilities for in-house Production and to serve the needs of our customers.Our OfferingsWe use Quality by Design tech...

Business Scope:

We are specialty chemicals and intermediates manufacturers, also can do CRO

Type of Enterprise:

Manufacturer

Location:

India 

Founded Date:

2020-03-01

Contact Supplier
Parmax Pharma Limited
Country: India
Tel: +91-9428003765
Mobile: +91-9428003765
E-mail: info@parmaxpharma.com
WhatsApp: Chat Now!
Skype: Chat Now!